Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Auditor change
Benitec Biopharma Inc. (BNTC) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/20/2021 8-K Quarterly results
09/23/2020 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : September 23, 2020 BENITEC BIOPHARMA INC. Delaware 001-39267 84-462-0206 3940 Trust Way, Hayward, California 94545 Registrant's Telephone Number, Including Area Code: 780-0819 : Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-...",
"Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy